https://scholars.lib.ntu.edu.tw/handle/123456789/633853
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Hsu, Yu-Chen | en_US |
dc.contributor.author | CHIEN-HUNG CHEN | en_US |
dc.contributor.author | HUI-FU HUANG | en_US |
dc.contributor.author | Lee, Ying-Te | en_US |
dc.contributor.author | Wu, Meng-Chuan | en_US |
dc.contributor.author | Su, Chien-Wen | en_US |
dc.contributor.author | Chou, Huei-Chi | en_US |
dc.contributor.author | Wang, Li-Fang | en_US |
dc.contributor.author | Lee, Hsuan-Shu | en_US |
dc.contributor.author | SHU-WHA LIN | en_US |
dc.contributor.author | PING-NING HSU | en_US |
dc.contributor.author | YAO-MING WU | en_US |
dc.contributor.author | Sheu, Jin-Chuan | en_US |
dc.contributor.author | Weng, Meng-Tzu | en_US |
dc.date.accessioned | 2023-07-18T01:20:47Z | - |
dc.date.available | 2023-07-18T01:20:47Z | - |
dc.date.issued | 2023-07-01 | - |
dc.identifier.issn | 00411337 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/633853 | - |
dc.description.abstract | Liver transplantation (LT) is the treatment of choice for patients with hepatocellular carcinoma (HCC). Recurrence of HCC after LT occurs in 10% to 20% of cases. Preclinical studies to evaluate immune checkpoint inhibitors in conjunction with immunosuppressant treatment in transplant recipients have been lacking. Here, we evaluated the efficacy, safety, and mechanism of programmed cell death-1 (PD1) blockade under tacrolimus treatment in transplant recipients. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Transplantation | en_US |
dc.title | Therapeutic Effects of Anti-PD1 Immunotherapy on Hepatocellular Carcinoma Under Administration of Tacrolimus | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1097/TP.0000000000004425 | - |
dc.identifier.pmid | 36380450 | - |
dc.identifier.scopus | 2-s2.0-85163537475 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85163537475 | - |
dc.relation.journalvolume | 107 | en_US |
dc.relation.journalissue | 7 | en_US |
dc.relation.pageend | 1501 | en_US |
item.languageiso639-1 | en | - |
item.openairetype | journal article | - |
item.fulltext | no fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Biotechnology | - |
crisitem.author.dept | Clinical Laboratory Sciences and Medical Biotechnology | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.dept | Surgery-NTUCC | - |
crisitem.author.orcid | 0000-0003-4979-3761 | - |
crisitem.author.orcid | 0000-0002-2451-9654 | - |
crisitem.author.orcid | 0000-0002-8017-0434 | - |
crisitem.author.orcid | 0000-0001-6748-5581 | - |
crisitem.author.orcid | 0000-0003-4479-3391 | - |
crisitem.author.orcid | 0000-0002-1720-7863 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Bioresources and Agriculture | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Cancer Center (NTUCC) | - |
顯示於: | 生物科技研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。